Watchlist Price Alert

Kymera Therapeutics Inc. (KYMR)

NASDAQ: KYMR · Real-Time Price · USD

29.76

-1.38 (-4.43%)

At close: May 14, 2025, 3:59 PM

30.33

1.92%

After-hours: May 14, 2025, 05:13 PM EDT

Kymera Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Cash & Equivalents	120.26M	109.97M	68.39M	47.98M	31M	76.02M	41.26M
Short-Term Investments	368.49M	264.92M	338.77M	394.44M	265.2M	15.94M	n/a
Long-Term Investments	362.16M	61.43M	152.33M	125.19M	162.53M	1.77M	199K
Other Long-Term Assets	7.74M	7.93M	-122.02M	-98.77M	11.46M	n/a	n/a
Receivables	947K	18.76M	2.54M	135K	1.43M	n/a	148K
Inventory	n/a	n/a	-12.25M	-8.99M	-163.39M	n/a	n/a
Other Current Assets	20.58M	11.67M	9.71M	n/a	n/a	n/a	n/a
Total Current Assets	510.27M	405.32M	559.49M	567.61M	302.34M	92.84M	41.79M
Property-Plant & Equipment	97.86M	101.08M	13.33M	11.88M	10.84M	22.08M	2.24M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	467.77M	170.44M	43.64M	38.3M	184.84M	23.86M	2.44M
Total Assets	978.03M	575.76M	603.13M	605.9M	487.18M	116.7M	44.23M
Account Payables	5.99M	7.08M	4.33M	4M	4.37M	3.28M	2.06M
Deferred Revenue	13.58M	37.88M	63.26M	101.03M	170.39M	23.35M	2.32M
Short-Term Debt	13.11M	n/a	3.94M	3.6M	3.26M	n/a	n/a
Other Current Liabilities	35.09M	23.16M	15.71M	-3.37M	2.67M	2.71M	1.31M
Total Current Liabilities	67.77M	85.69M	63.26M	101.03M	110.62M	34.57M	4.69M
Long-Term Debt	n/a	n/a	13.39M	14.36M	14.73M	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	-13.14M	-14.3M	-14.63M	109.08M	73.59M
Total Long-Term Liabilities	74.65M	95.1M	49.72M	45.23M	92.67M	156.54M	73.98M
Total Liabilities	142.42M	180.79M	112.98M	146.27M	203.29M	191.11M	78.67M
Total Debt	87.76M	84.67M	17.34M	17.96M	17.99M	21.19M	695K
Common Stock	7K	6K	6K	5K	4K	n/a	n/a
Retained Earnings	-754.61M	-530.75M	-383.79M	-228.98M	-128.76M	-76.46M	-35.21M
Comprehensive Income	-1.49M	-552K	-4.95M	-660K	-128K	6K	n/a
Shareholders Equity	835.62M	394.97M	490.15M	459.64M	283.89M	-74.41M	-34.44M
Total Investments	730.65M	326.35M	491.1M	519.63M	427.73M	15.94M	199K